Towards a mechanistic understanding of reciprocal drug–microbiome interactions

  • Zimmermann M
  • Patil K
  • Typas A
  • et al.
83Citations
Citations of this article
158Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The collection of fecal material and developments in sequencing technologies have enabled standardised and non-invasive gut microbiome profiling. Microbiome composition from several large cohorts have been cross-sectionally linked to various lifestyle factors and diseases. In spite of these advances, prospective associations between microbiome composition and health have remained uncharacterised due to the lack of sufficiently large and representative population cohorts with comprehensive follow-up data. Here, we analyse the long-term association between gut microbiome variation and mortality in a well-phenotyped and representative population cohort from Finland (n = 7211). We report robust taxonomic and functional microbiome signatures related to the Enterobacteriaceae family that are associated with mortality risk during a 15-year follow-up. Our results extend previous cross-sectional studies, and help to establish the basis for examining long-term associations between human gut microbiome composition, incident outcomes, and general health status.

Cite

CITATION STYLE

APA

Zimmermann, M., Patil, K. R., Typas, A., & Maier, L. (2021). Towards a mechanistic understanding of reciprocal drug–microbiome interactions. Molecular Systems Biology, 17(3). https://doi.org/10.15252/msb.202010116

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free